The Clinical & Translational Science Institute at the University of Rochester has received a $21 million grant from the National Institutes of Health to support programs focused on breaking down the barriers between research labs and the lives of people, university officials announced Thursday.
The Clinical and Translational Science Award, effective July 1, will enable the University of Rochester Medical Center to continue work in clinical and translational medicine for another five years. The grant is a renewal of a $40 million award made to URMC in 2006 to create and expand research, education and support programs intended to cut the time needed to turn scientific insight into new ways to treat disease.
In April the institute opened a new 200,000-square-foot building dedicated to clinical and translational science, the Saunders Research Building.
The $21 million grant will support the activity of the institute, which was created in 2006 to provide researchers with a comprehensive and integrated set of services, expertise and resources necessary to carry out all phases of translational research, URMC officials said. The institute also funds pilot research, oversees new graduate programs in translational medicine, and serves as the nucleus for a coalition of 16 biomedical research centers in upstate New York.
The new grant brings the total support for the institute and its affiliated programs to $65 million. URMC officials also estimate the institute has played a role in another $234 million in research and education grants awarded to researchers at URMC and other institutions over the last five years.
The award will support the work of several translational medicine initiatives, including more public-private partnerships, the Center for Human Experimental Therapeutics and the Center for Research Implementation and Translation, a partnership between the school of nursing and departments of community and preventative medicine and psychiatry that conducts research into the benefits and harms of different medical interventions.
“This grant is a testament to the efforts of scores of faculty and staff who have contributed to the enormous progress we have made over the last five years,” said Thomas Pearson, the principal investigator of the CTSA grant. “At the same time it requires that we not rest on our laurels but continue to innovate and build the teams necessary to tackle the complex health problems that burden our patients and communities.”
(c) 2011 Rochester Business Journal. To obtain permission to reprint this article, call 585-546-8303 or e-mail email@example.com.